Largos supervivientes con aflibercept - page 7

Características clínicas y patológicas de los pacientes

tratados en segunda línea con 25 ciclos o más de

FOLFIRI + Aflibercept.

Pericay, C. et al P-051. Presented at the 18th WCGIC

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6 8,9,10,11,12,13,14